MARATTO

article · African Journal of Biochemistry Research

Hyperhomocysteinemia in a population of type 2 diabetics in Senegal

2024Open accessUniversité de Thiès

Abstract

The objective of this study is to estimate the prevalence of hyperhomocysteinemia in a population of type 2 diabetics and to study the relationship between serum homocysteine ??levels and sociodemographic, clinical and biological characteristics in this population. This is a cross-sectional study involving 100 type 2 diabetic patients. Each patient underwent a routine biological assessment and a total homocysteinemia measurement. The overall prevalence of hyperhomocysteinemia is 27% (95% confidence interval : 18.6 to 36.8). The mean serum homocysteine ??value is 10.7±3.7 μmol/l and it is higher in men (11.5 ± 3.7 μmol/l) than in women (10.4 ± 3.7 μmol/l) with a non-significant difference (p=0.901). We found a positive significant correlation between homocysteinemia and creatinine (p = 0.03) and a negative significant correlation between homocysteinemia and serum HDL cholesterolemia (p=0.01). Mean serum homocysteine ??levels is significantly higher in hypertensive diabetics subjects than in non-hypertensive patients (p=0.006). The prevalence of hyperhomocysteinemia is relatively high in type 2 diabetics. This marker should be determined as part of the biological monitoring of these patients.   Key words: Hyperhomocysteinemia, risk factor, type 2 diabetes, Senegal.

Research topics

  • Folate and B Vitamins Research
  • HIV-related health complications and treatments
  • Nutrition and Health in Aging

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5897/ajbr2023.1180

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.